Our data aboutelevated serum IL-1β, TNF-α and decreased IL-2,IL-6 levels in newly diagnosed IDDM patients in comparisonwith longer standing cases supports an activation of systemicinflammatory process during early phases of IDDM which may beindicative of an ongoing β-cell destruction. The gene discussed is TNF; the disease is type 1 diabetes mellitus.